Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 469

1.

Quantitative biparametric analysis of hybrid 18F-FET PET/MR-neuroimaging for differentiation between treatment response and recurrent glioma.

Lohmeier J, Bohner G, Siebert E, Brenner W, Hamm B, Makowski MR.

Sci Rep. 2019 Oct 10;9(1):14603. doi: 10.1038/s41598-019-50182-4.

2.

Comparison of glomerular filtration rate (GFR) with Tc-99m-DTPA and tubular extraction rate (TER) with Tc-99m-MAG3 in potential living kidney donors: Feasibility of a one-day protocol.

Rogasch JMM, Bamm M, Bäder M, Jaeschke E, Brenner W, van der Giet M, Amthauer H, Schatka I.

Nuklearmedizin. 2019 Oct 10. doi: 10.1055/a-1015-0096. [Epub ahead of print]

PMID:
31600814
3.

[The teaching of nuclear medicine in Germany].

Heinzel A, Mottaghy FM, Brenner W, Marienhagen J.

Nuklearmedizin. 2019 Oct 10. doi: 10.1055/a-1011-3481. [Epub ahead of print] German.

PMID:
31600813
4.

CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.

Erdmann S, Niederstadt L, Koziolek EJ, Gómez JDC, Prasad S, Wagener A, von Hacht JL, Reinicke S, Exner S, Bandholtz S, Beindorff N, Brenner W, Grötzinger C.

Theranostics. 2019 Sep 19;9(22):6719-6733. doi: 10.7150/thno.34857. eCollection 2019.

5.

Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.

Stergiou N, Nagel J, Pektor S, Heimes AS, Jäkel J, Brenner W, Schmidt M, Miederer M, Kunz H, Roesch F, Schmitt E.

Int J Med Sci. 2019 Aug 14;16(9):1188-1198. doi: 10.7150/ijms.35452. eCollection 2019.

6.

Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.

Steinemann G, Dittmer A, Schmidt J, Josuttis D, Fähling M, Biersack B, Beindorff N, Jolante Koziolek E, Schobert R, Brenner W, Müller T, Nitzsche B, Höpfner M.

Mol Oncol. 2019 Oct 4. doi: 10.1002/1878-0261.12582. [Epub ahead of print]

7.

[Preclinical (Radionuclide) Imaging Centers].

Brenner W, Beindorff N.

Nuklearmedizin. 2019 Sep;58(5):348-350. doi: 10.1055/a-0972-0758. Epub 2019 Sep 19. German. No abstract available.

PMID:
31537042
8.

The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literature.

Boutas I, Potiris A, Brenner W, Lebrecht A, Hasenburg A, Kalantaridou S, Schmidt M.

Arch Gynecol Obstet. 2019 Nov;300(5):1113-1120. doi: 10.1007/s00404-019-05292-9. Epub 2019 Sep 9. Review.

PMID:
31502061
9.

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE.

Graf J, Pape UF, Jann H, Denecke T, Arsenic R, Brenner W, Pavel M, Prasad V.

Eur J Nucl Med Mol Imaging. 2019 Aug 14. doi: 10.1007/s00259-019-04439-9. [Epub ahead of print]

PMID:
31414209
10.

Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to 68Ga-PSMA PET-CT.

Meißner S, Janssen JC, Prasad V, Diederichs G, Hamm B, Brenner W, Makowski MR.

Sci Rep. 2019 Jul 24;9(1):10727. doi: 10.1038/s41598-019-46386-3.

11.

3D nonrigid motion correction for quantitative assessment of hepatic lesions in DCE-MRI.

Ippoliti M, Lukas M, Brenner W, Schaeffter T, Makowski MR, Kolbitsch C.

Magn Reson Med. 2019 Nov;82(5):1753-1766. doi: 10.1002/mrm.27867. Epub 2019 Jun 22.

12.

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer.

Damjanovic J, Janssen JC, Prasad V, Diederichs G, Walter T, Brenner W, Makowski MR.

Cancer Imaging. 2019 Jun 11;19(1):37. doi: 10.1186/s40644-019-0220-x.

13.

Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.

von Hacht JL, Erdmann S, Niederstadt L, Prasad S, Wagener A, Exner S, Beindorff N, Brenner W, Grötzinger C.

PLoS One. 2019 Jun 4;14(6):e0217883. doi: 10.1371/journal.pone.0217883. eCollection 2019.

14.

Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.

Rohwer N, Jumpertz S, Erdem M, Egners A, Warzecha KT, Fragoulis A, Kühl AA, Kramann R, Neuss S, Rudolph I, Endermann T, Zasada C, Apostolova I, Gerling M, Kempa S, Hughes R, Lewis CE, Brenner W, Malinowski MB, Stockmann M, Schomburg L, Faller W, Sansom OJ, Tacke F, Morkel M, Cramer T.

Oncogene. 2019 Jul;38(28):5670-5685. doi: 10.1038/s41388-019-0816-4. Epub 2019 May 1.

15.

Diffusion-weighted magnetic resonance imaging using a preclinical 1 T PET/MRI in healthy and tumor-bearing rats.

Albrecht J, Polenz D, Kühl AA, Rogasch JMM, Leder A, Sauer IM, Babos M, Mócsai G, Beindorff N, Steffen IG, Brenner W, Koziolek EJ.

EJNMMI Res. 2019 Feb 22;9(1):21. doi: 10.1186/s13550-019-0489-6.

16.

Normal Values for Parotid Gland and Submandibular-Sublingual Salivary Gland Complex Uptake of 99mTechnetium Pertechnetate using SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.

Huang EL, Steffen IG, Lukas M, Huang K, Aschenbach JR, Eary JF, Brenner W, Beindorff N.

Nuklearmedizin. 2019 Feb;58(1):39-49. doi: 10.1055/a-0810-0174. Epub 2019 Feb 15.

PMID:
30769372
17.

High Level of Conservation of Mitochondrial RNA Editing Sites Among Four Populus Species.

Brenner WG, Mader M, Müller NA, Hoenicka H, Schroeder H, Zorn I, Fladung M, Kersten B.

G3 (Bethesda). 2019 Mar 7;9(3):709-717. doi: 10.1534/g3.118.200763.

18.

Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancy.

Frees SK, Kamal MM, Nestler S, Levien PM, Bidnur S, Brenner W, Thomas C, Jaeger W, Thüroff JW, Roos FC.

Int J Urol. 2019 Mar;26(3):385-390. doi: 10.1111/iju.13882. Epub 2018 Dec 26.

PMID:
30588677
19.

Normal Values of Renal Function measured with 99mTechnetium Mercaptoacetyltriglycine SPECT in Mice with Respect to Age, Sex and Circadian Rhythm.

Huang K, Lukas M, Steffen IG, Lange C, Huang EL, Dorau V, Brenner W, Beindorff N.

Nuklearmedizin. 2018 Dec;57(6):224-233. doi: 10.3413/Nukmed-0999-18-09. Epub 2018 Dec 18.

PMID:
30562811
20.

Primary Mucosal Epithelial Cell Cultivation: A Reliable and Accelerated Isolation.

Bauer HK, Flesch D, Walenta S, Unger RE, Schwab R, Nezi-Cahn S, Hasenburg A, Heller M, Brenner W.

Tissue Eng Part C Methods. 2019 Feb;25(2):82-92. doi: 10.1089/ten.TEC.2018.0327.

PMID:
30501564
21.

Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand Therapies.

Huang K, Brenner W, Prasad V.

J Nucl Med. 2019 Jun;60(6):752-755. doi: 10.2967/jnumed.118.217380. Epub 2018 Nov 21.

PMID:
30464038
22.

Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

Kurch L, Hasenclever D, Kluge R, Georgi T, Tchavdarova L, Golombeck M, Sabri O, Eggert A, Brenner W, Sykora KW, Bengel FM, Rossig C, Körholz D, Schäfers M, Feuchtinger T, Bartenstein P, Ammann RA, Krause T, Urban C, Aigner R, Gattenlöhner S, Klapper W, Mauz-Körholz C.

Pediatr Blood Cancer. 2019 Mar;66(3):e27539. doi: 10.1002/pbc.27539. Epub 2018 Nov 14.

PMID:
30426671
23.

Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid.

Stergiou N, Gaidzik N, Heimes AS, Dietzen S, Besenius P, Jäkel J, Brenner W, Schmidt M, Kunz H, Schmitt E.

Cancer Immunol Res. 2019 Jan;7(1):113-122. doi: 10.1158/2326-6066.CIR-18-0256. Epub 2018 Nov 9.

PMID:
30413430
24.

A retrospective analysis of immunohistochemically determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients.

Heimes AS, Schmidt M, Jäkel J, Almstedt K, Gebhard S, Weyer-Eiberich V, Elger T, Krajnak S, Brenner W, Hasenburg A, Battista MJ.

Arch Gynecol Obstet. 2019 Jan;299(1):239-246. doi: 10.1007/s00404-018-4941-z. Epub 2018 Oct 24.

PMID:
30357498
25.

Size-Selective Hydroformylation by a Rhodium Catalyst Confined in a Supramolecular Cage.

Nurttila SS, Brenner W, Mosquera J, van Vliet KM, Nitschke JR, Reek JNH.

Chemistry. 2019 Jan 7;25(2):609-620. doi: 10.1002/chem.201804333. Epub 2018 Dec 11.

26.

Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients.

Krajnak S, Battista M, Brenner W, Almstedt K, Elger T, Heimes AS, Hasenburg A, Schmidt M.

Breast Care (Basel). 2018 Aug;13(4):272-276. doi: 10.1159/000487629. Epub 2018 May 3.

27.

Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm.

Beindorff N, Bartelheimer A, Huang K, Lukas M, Lange C, Huang EL, Aschenbach JR, Eary JF, Steffen IG, Brenner W.

Nuklearmedizin. 2018 Sep;57(5):181-189. doi: 10.3413/Nukmed-0978-18-05. Epub 2018 Sep 28.

PMID:
30267400
28.

[Development of a national competency-based learning objective catalogue for undergraduate medical education in Germany].

Marienhagen J, Brenner W, Buck A, Franzius C, Freudenberg LS, Gotthardt M, Lindner O, Mottaghy FM, Hellwig D.

Nuklearmedizin. 2018 Aug;57(4):137-145. doi: 10.3413/Nukmed-0969-18-03. Epub 2018 Aug 20. German.

PMID:
30125926
29.

High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.

Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A; German Network Of Kidney Cancer.

Hum Pathol. 2019 Jan;83:212-223. doi: 10.1016/j.humpath.2018.08.006. Epub 2018 Aug 17.

PMID:
30121370
30.

Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent.

Wiesmann N, Kluenker M, Demuth P, Brenner W, Tremel W, Brieger J.

J Trace Elem Med Biol. 2019 Jan;51:226-234. doi: 10.1016/j.jtemb.2018.08.002. Epub 2018 Aug 7.

PMID:
30115501
31.

Ga-68-PSMA PET/CT in treatment-naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA-positive metastases?

Rogasch JM, Cash H, Zschaeck S, Elezkurtaj S, Brenner W, Hamm B, Makowski M, Amthauer H, Furth C, Baur ADJ.

Prostate. 2018 Jul 5. doi: 10.1002/pros.23685. [Epub ahead of print]

PMID:
29978529
32.

In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.

Breuksch I, Welter J, Bauer HK, Enklaar T, Frees S, Thüroff JW, Hasenburg A, Prawitt D, Brenner W.

Cell Commun Signal. 2018 Jun 28;16(1):35. doi: 10.1186/s12964-018-0247-9.

33.

The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells.

Kiweler N, Brill B, Wirth M, Breuksch I, Laguna T, Dietrich C, Strand S, Schneider G, Groner B, Butter F, Heinzel T, Brenner W, Krämer OH.

Arch Toxicol. 2018 Jul;92(7):2227-2243. doi: 10.1007/s00204-018-2229-5. Epub 2018 May 29.

PMID:
29845424
34.

Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

Frees S, Breuksch I, Haber T, Bauer HK, Chavez-Munoz C, Raven P, Moskalev I, D Costa N, Tan Z, Daugaard M, Thüroff JW, Haferkamp A, Prawitt D, So A, Brenner W.

Oncotarget. 2018 Mar 2;9(21):15766-15779. doi: 10.18632/oncotarget.24607. eCollection 2018 Mar 20.

35.

Willkommen im Bremen.

Brenner W.

Nuklearmedizin. 2018 Apr;57(2):N9. doi: 10.1055/s-0038-1641691. Epub 2018 Mar 28. German. No abstract available.

PMID:
29590673
36.

DNA double-strand breaks in blood lymphocytes induced by two-day 99mTc-MIBI myocardial perfusion scintigraphy.

Rief M, Hartmann L, Geisel D, Richter F, Brenner W, Dewey M.

Eur Radiol. 2018 Jul;28(7):3075-3081. doi: 10.1007/s00330-017-5239-4. Epub 2018 Jan 30.

PMID:
29383524
37.

Allene oxide synthase, allene oxide cyclase and jasmonic acid levels in Lotus japonicus nodules.

Zdyb A, Salgado MG, Demchenko KN, Brenner WG, Płaszczyca M, Stumpe M, Herrfurth C, Feussner I, Pawlowski K.

PLoS One. 2018 Jan 5;13(1):e0190884. doi: 10.1371/journal.pone.0190884. eCollection 2018.

38.

Integrin α5 triggers the metastatic potential in renal cell carcinoma.

Breuksch I, Prosinger F, Baehr F, Engelhardt FP, Bauer HK, Thüroff JW, Heimes AS, Hasenburg A, Prawitt D, Brenner W.

Oncotarget. 2017 Nov 18;8(64):107530-107542. doi: 10.18632/oncotarget.22501. eCollection 2017 Dec 8.

39.

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions.

Meißner S, Janssen JC, Prasad V, Brenner W, Diederichs G, Hamm B, Hofheinz F, Makowski MR.

EJNMMI Res. 2017 Oct 23;7(1):85. doi: 10.1186/s13550-017-0333-9.

40.

Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.

Ishibashi K, Haber T, Breuksch I, Gebhard S, Sugino T, Kubo H, Hata J, Koguchi T, Yabe M, Kataoka M, Ogawa S, Hiraki H, Yanagida T, Haga N, Thüroff JW, Prawitt D, Brenner W, Kojima Y.

Oncotarget. 2017 Jul 21;8(33):55230-55245. doi: 10.18632/oncotarget.19420. eCollection 2017 Aug 15.

41.

Approaches and techniques to characterize cancer metabolism in vitro and in vivo.

Zaimenko I, Lisec J, Stein U, Brenner W.

Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):412-419. doi: 10.1016/j.bbcan.2017.08.004. Epub 2017 Sep 5. Review.

PMID:
28887205
42.

Individualized risk assessment in neuroblastoma: does the tumoral metabolic activity on 123I-MIBG SPECT predict the outcome?

Rogasch JMM, Hundsdoerfer P, Furth C, Wedel F, Hofheinz F, Krüger PC, Lode H, Brenner W, Eggert A, Amthauer H, Schatka I.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2203-2212. doi: 10.1007/s00259-017-3786-1. Epub 2017 Aug 14.

PMID:
28808732
43.

Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT.

Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR.

Eur Radiol. 2018 Feb;28(2):610-619. doi: 10.1007/s00330-017-4994-6. Epub 2017 Aug 4.

PMID:
28779400
44.

Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer.

Woythal N, Arsenic R, Kempkensteffen C, Miller K, Janssen JC, Huang K, Makowski MR, Brenner W, Prasad V.

J Nucl Med. 2018 Feb;59(2):238-243. doi: 10.2967/jnumed.117.195172. Epub 2017 Aug 3.

45.

[68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients.

Janssen JC, Woythal N, Meißner S, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR.

Mol Imaging Biol. 2017 Dec;19(6):933-943. doi: 10.1007/s11307-017-1101-y.

PMID:
28707038
46.

Thiourea derivatives as chelating agents for bioconjugation of rhenium and technetium.

Gomez JDC, Hagenbach A, Gerling-Driessen UIM, Koksch B, Beindorff N, Brenner W, Abram U.

Dalton Trans. 2017 Oct 31;46(42):14602-14611. doi: 10.1039/c7dt01834g.

PMID:
28702615
47.

Evaluation of bone viability in patients after girdlestone arthroplasty: comparison of bone SPECT/CT and MRI.

Diederichs G, Hoppe P, Collettini F, Wassilew G, Hamm B, Brenner W, Makowski MR.

Skeletal Radiol. 2017 Sep;46(9):1249-1258. doi: 10.1007/s00256-017-2692-8. Epub 2017 Jun 16.

PMID:
28623409
48.

Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer.

Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Elger T, Krajnak S, Rahnenführer J, Brenner W, Hasenburg A, Hengstler JG, Schmidt M.

Breast Cancer Res Treat. 2017 Sep;165(2):293-300. doi: 10.1007/s10549-017-4327-0. Epub 2017 Jun 5.

PMID:
28585074
49.

Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome.

Apostolova I, Taleb DS, Lipp A, Galazky I, Kupitz D, Lange C, Makowski MR, Brenner W, Amthauer H, Plotkin M, Buchert R.

Clin Nucl Med. 2017 Aug;42(8):589-594. doi: 10.1097/RLU.0000000000001696.

PMID:
28574876
50.

Analysis of CFB, a cytokinin-responsive gene of Arabidopsis thaliana encoding a novel F-box protein regulating sterol biosynthesis.

Brenner WG, Leuendorf JE, Cortleven A, Martin LBB, Schaller H, Schmülling T.

J Exp Bot. 2017 May 17;68(11):2769-2785. doi: 10.1093/jxb/erx146.

Supplemental Content

Loading ...
Support Center